Risk of Thromboembolism in Patients Receiving Immunotherapy-Based Combinations as Front-Line Therapy for Metastatic Renal Cell Carcinoma.
第一作者:
James,Schuster
第一单位:
Cleveland Clinic, Cleveland OH. Electronic address: schustj5@ccf.org.
作者:
医学主题词
人类(Humans);男(雄)性(Male);老年人(Aged);女(雌)性(Female);癌, 肾细胞(Carcinoma, Renal Cell);肾肿瘤(Kidney Neoplasms);血管内皮生长因子A(Vascular Endothelial Growth Factor A);回顾性研究(Retrospective Studies);蛋白激酶抑制剂(Protein Kinase Inhibitors);血管生成抑制剂(Angiogenesis Inhibitors);免疫疗法(Immunotherapy)
DOI
10.1016/j.clgc.2023.09.005
PMID
37932205
发布时间
2024-04-09
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



